New depression treatment targets the immune system instead of the brain
Immunotherapy may offer a completely new way to treat people with difficult-to-treat depression, according to a University of Bristol-led clinical trial published in JAMA Psychiatry on May 20.
In the small pilot study, researchers tested whether tocilizumab, a drug commonly prescribed for…